| Study of Remdesivir in Participants Below 18 Years Old With COVID-19 | 2020-07-21 | 2023-02-10 | 2023-11-28 |
| Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma | 2019-11-05 | 2023-01-30 | 2024-01-09 |
| Study of Cilofexor in Adults With Primary Sclerosing Cholangitis | 2019-03-27 | 2022-11-10 | 2023-11-06 |
| Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) | 2021-03-31 | 2022-04-20 | 2023-04-18 |
| Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD) | 2019-05-31 | 2022-04-05 | |
| Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults | 2018-05-30 | 2022-02-25 | 2023-02-17 |
| Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With Other Antiretroviral Agents in People Living With HIV | 2019-11-22 | 2021-09-30 | 2022-09-29 |
| Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease | 2019-07-24 | 2021-09-03 | 2022-08-31 |
| Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers | 2017-12-27 | 2021-06-30 | |
| Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma | 2019-01-29 | 2021-05-17 | 2022-05-16 |
| Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting | 2020-09-18 | 2021-05-06 | 2021-11-04 |
| Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis | 2019-10-16 | 2021-03-26 | 2022-03-23 |
| Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma | 2018-01-25 | 2021-03-18 | 2023-12-20 |
| Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis | 2019-12-20 | 2021-02-25 | 2022-07-29 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease | 2017-04-06 | 2021-01-20 | 2022-02-16 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy | 2019-12-03 | 2021-01-19 | 2022-01-18 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy | 2019-11-13 | 2021-01-04 | 2021-12-30 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis | 2017-07-26 | 2020-12-29 | 2021-12-23 |
| Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) | 2016-06-13 | 2020-12-17 | 2022-01-04 |
| Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD) | 2019-04-17 | 2020-11-26 | 2022-10-03 |
| Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection | 2020-01-03 | 2020-11-12 | 2021-09-29 |
| Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance | 2019-11-21 | 2020-10-05 | 2021-09-28 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD) | 2017-04-11 | 2020-07-20 | 2021-07-15 |
| Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH) | 2019-07-29 | 2020-07-13 | 2021-06-25 |
| Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria | 2017-11-28 | 2020-05-27 | 2022-03-02 |
| Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children | 2013-05-06 | 2020-05-11 | 2021-04-29 |
| Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment | 2020-03-15 | 2020-04-29 | 2020-12-15 |
| Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) | 2020-03-06 | 2020-04-09 | 2020-12-15 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis | 2016-11-14 | 2020-03-31 | 2021-03-23 |
| Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) | 2017-11-07 | 2020-03-30 | 2021-03-11 |
| Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB) | 2018-02-28 | 2020-01-20 | 2022-03-08 |
| Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment | 2018-08-28 | 2019-12-12 | 2020-12-10 |
| Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection | 2019-01-28 | 2019-12-04 | 2020-08-13 |
| Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection | 2017-01-26 | 2019-11-19 | 2020-08-24 |
| Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2- Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen | 2015-01-20 | 2019-11-04 | 2020-11-02 |
| Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) | 2018-03-21 | 2019-10-30 | 2020-10-16 |
| Study of Ambrisentan in Participants With Pulmonary Hypertension | 2008-11-17 | 2019-09-11 | 2020-09-08 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis | 2016-12-01 | 2019-09-04 | 2019-12-19 |
| Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants | 2018-08-28 | 2019-08-12 | 2020-08-12 |
| Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2) | 2015-11-09 | 2019-07-24 | 2020-08-21 |
| Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis | 2017-02-13 | 2019-06-19 | 2020-06-10 |
| Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) | 2016-12-13 | 2019-06-17 | 2020-06-12 |
| Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela ) | 2012-06-15 | 2019-06-10 | 2017-12-18 |
| Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | 2015-10-13 | 2019-05-15 | 2020-04-15 |
| Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) | 2017-01-30 | 2019-05-06 | 2020-04-24 |
| Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN) | 2017-10-06 | 2019-05-03 | 2020-05-01 |
| Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) | 2017-06-29 | 2019-03-27 | 2020-03-24 |
| Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B | 2018-04-06 | 2019-03-22 | 2020-03-18 |
| Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) | 2017-05-24 | 2019-03-13 | 2020-03-09 |
| Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL) | 2017-04-06 | 2019-02-20 | 2020-02-14 |